Company description

Bionano Genomics Inc. (ticker symbol: BNGO) is a leading life sciences company specializing in genetic analysis and diagnostics. Their innovative platform, Saphyr, uses advanced optical mapping technology to analyze genomes, providing researchers and clinicians with highly accurate and comprehensive analysis results. Bionano is dedicated to revolutionizing the way genetic diseases are diagnosed and treated, with a focus on rare genetic disorders and oncology. In addition to their flagship Saphyr platform, Bionano offers a range of products and services to support genetic analysis and diagnostics, including consumables, software, instrumentation, and bioinformatics solutions. With a team of experts in genetics, engineering, and software development, Bionano is committed to advancing the field of genomics and improving patient outcomes. They have a strong track record of successful collaborations with leading research institutions and healthcare organizations, and continue to expand their global reach. Bionano is poised for continued growth and innovation, making them a promising company to watch in the ever-evolving field of genetics and diagnostic testing.